These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Immunobiology of the inner ear. Harris JP; Ryan AF Am J Otolaryngol; 1984; 5(6):418-25. PubMed ID: 6400717 [TBL] [Abstract][Full Text] [Related]
64. Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease. Saraçaydin A; Katircioglu S; Katircioglu S; Karatay MC J Int Med Res; 1993; 21(4):192-6. PubMed ID: 8112477 [TBL] [Abstract][Full Text] [Related]
65. Acquired Glanzmann's thrombasthenia with optimal response to rituximab therapy. Solh M; Mescher C; Klappa A; Shah S; Zantek N; Datta Y Am J Hematol; 2011 Aug; 86(8):715-6. PubMed ID: 21761438 [No Abstract] [Full Text] [Related]
66. Review of the biologic agents used for immune-mediated inner ear disease. Lobo D; García-Berrocal JR; Trinidad A; Verdaguer JM; Ramírez-Camacho R Acta Otorrinolaringol Esp; 2013; 64(3):223-9. PubMed ID: 22770424 [TBL] [Abstract][Full Text] [Related]
78. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Helfgott SM; Mosciscki RA; San Martin J; Lorenzo C; Kieval R; McKenna M; Nadol J; Trentham DE Lancet; 1991 Feb; 337(8738):387-9. PubMed ID: 1671423 [TBL] [Abstract][Full Text] [Related]
79. An open label study to evaluate the safety and efficacy of intratympanic golimumab therapy in patients with autoimmune inner ear disease. Derebery MJ; Fisher LM; Voelker CC; Calzada A Otol Neurotol; 2014 Oct; 35(9):1515-21. PubMed ID: 25203561 [TBL] [Abstract][Full Text] [Related]
80. Predictive value of laboratory tests in "autoimmune" inner ear disease: preliminary report. Hughes GB; Barna BP; Kinney SE; Calabrese LH; Nalepa NL Laryngoscope; 1986 May; 96(5):502-5. PubMed ID: 3702564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]